Anxiolytic and antidepressant potential of extracts of Duchesnea Indica in animal models
- PMID: 36649439
- PMCID: PMC9840006
Anxiolytic and antidepressant potential of extracts of Duchesnea Indica in animal models
Abstract
THIS study was designed to investigate the anxiolytic and antidepressant activity of Duchesnea Indica. The methanolic extract and n-hexane fraction of plant were tested in albino mice (20-30 g of 6-8 week). Safety profile of each extract was determined at different doses. Anxiolytic effect of plant was determined by Elevated Plus Maze and Light and Dark Model at different doses of methanolic and n-hexane extract. Antidepressant activities were assisted by Tail Suspension and Forced Swim Model at different doses. Result illustrated that D. Indica had a significant (P < 0.05) potential of reducing anxiety and depression. The methanolic extract at 100 mg and 200 mg significantly increased the time spend in light region of light and dark model and more time spent in open arm of Elevated Plus Maze model. n-hexane extract at dose of 5 mg and 10 mg/kg significantly increases the time spend in light region of Light and dark model and more time spend in open arm of Elevated Plus Maze model as compare to Control group. Methanolic extract of D. Indica significantly reduced the time of immobility in Tail Suspension and Force Swim Model at Dose of 100 mg and 200mg/kg. n-hexane extract also exhibit anti-depressant effect by reducing the time of immobility in Force swim and tail suspension Model at 100 mg and 200mg/kg dose as compare to control group. From the above observations, it could be assumed that the plant has marked anxiolytic and antidepressant potential. However further additional studies will be necessary to determine the underlying exact mechanism and clinical uses.
Keywords: Anxiolytic and antidepressant effects; Duchesnea Indica; crude extract; hexane fraction.
Conflict of interest statement
Conflict of interest: The authors of this article have no conflict of interest.
Figures


Similar articles
-
Anxiolytic and Antidepressant Potential of Methanolic Extract of Neurada procumbens Linn. in Mice.Dose Response. 2023 Apr 13;21(2):15593258231169584. doi: 10.1177/15593258231169584. eCollection 2023 Apr-Jun. Dose Response. 2023. PMID: 37063345 Free PMC article.
-
Phytochemical screening, acute toxicity, anxiolytic and antidepressant activities of the Nelumbo nucifera fruit.Metab Brain Dis. 2017 Jun;32(3):743-749. doi: 10.1007/s11011-017-9963-x. Epub 2017 Feb 1. Metab Brain Dis. 2017. PMID: 28144887
-
Abutilon indicum Exhibits Anxiolytic and Antidepressant Effects in Mice Models.Dokl Biochem Biophys. 2021 Sep;500(1):341-346. doi: 10.1134/S1607672921050203. Epub 2021 Oct 25. Dokl Biochem Biophys. 2021. PMID: 34697741
-
Anxiolytic- and antidepressant-like activities of hydroethanol leaf extract of Newbouldia laevis (P.Beauv.) Seem. (Bignoniaceae) in mice.J Ethnopharmacol. 2020 Mar 1;249:112420. doi: 10.1016/j.jep.2019.112420. Epub 2019 Nov 20. J Ethnopharmacol. 2020. PMID: 31759112
-
Anxiolytic- and antidepressant-like activities of a methanolic extract of Morinda citrifolia Linn. (noni) fruit in mice: Involvement of benzodiazepine-GABAAergic, serotonergic and adrenergic systems.Biomed Pharmacother. 2017 Dec;96:944-952. doi: 10.1016/j.biopha.2017.11.148. Epub 2017 Dec 6. Biomed Pharmacother. 2017. PMID: 29217165
Cited by
-
Phyto-pharmacological Potential of Aegle marmelos (L.) for Neurological Disorders: Progress and Prospects.Recent Adv Food Nutr Agric. 2025;16(1):12-30. doi: 10.2174/012772574X289517240222045916. Recent Adv Food Nutr Agric. 2025. PMID: 38468524 Review.
References
-
- Bourin M, Hascoët M, 2003. The mouse light/dark box test. European Journal of Pharmacology 463, 55–65. - PubMed
-
- Campos AC, Fogaça MV, Aguiar DC, Guimaraes FS, 2013. Animal models of anxiety disorders and stress. Brazilian Journal of Psychiatry 35, S101–S111. - PubMed
-
- Chang X. r., Wang L, Li J, Wu D. s., 2016. Analysis of anti-depressant potential of curcumin against depression induced male albino wistar rats. Brain Research 1642, 219–225. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources